GB2167414B - Flavolignan derivatives and pharmaceutical compositions containing them - Google Patents

Flavolignan derivatives and pharmaceutical compositions containing them

Info

Publication number
GB2167414B
GB2167414B GB08528226A GB8528226A GB2167414B GB 2167414 B GB2167414 B GB 2167414B GB 08528226 A GB08528226 A GB 08528226A GB 8528226 A GB8528226 A GB 8528226A GB 2167414 B GB2167414 B GB 2167414B
Authority
GB
United Kingdom
Prior art keywords
flavolignan
derivatives
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08528226A
Other versions
GB2167414A (en
GB8528226D0 (en
Inventor
Reinhard Braatz
Klaus Gorler
Gunter Halbach
Hartwig Soicke
Karlheinz Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Original Assignee
Dr Madaus GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Madaus GmbH and Co filed Critical Dr Madaus GmbH and Co
Publication of GB8528226D0 publication Critical patent/GB8528226D0/en
Publication of GB2167414A publication Critical patent/GB2167414A/en
Application granted granted Critical
Publication of GB2167414B publication Critical patent/GB2167414B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
GB08528226A 1984-11-22 1985-11-15 Flavolignan derivatives and pharmaceutical compositions containing them Expired GB2167414B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (en) 1984-11-22 1984-11-22 FLAVOLIGNANE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS

Publications (3)

Publication Number Publication Date
GB8528226D0 GB8528226D0 (en) 1985-12-18
GB2167414A GB2167414A (en) 1986-05-29
GB2167414B true GB2167414B (en) 1989-01-11

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08528226A Expired GB2167414B (en) 1984-11-22 1985-11-15 Flavolignan derivatives and pharmaceutical compositions containing them

Country Status (29)

Country Link
JP (1) JPS61143377A (en)
KR (1) KR870001020B1 (en)
AR (1) AR240931A1 (en)
AT (1) AT393268B (en)
BE (1) BE903693A (en)
CA (1) CA1337124C (en)
CH (1) CH659473A5 (en)
CS (1) CS273610B2 (en)
DD (1) DD259191A1 (en)
DE (1) DE3442639A1 (en)
DK (1) DK164865C (en)
EG (1) EG19424A (en)
ES (1) ES8609311A1 (en)
FI (1) FI84064C (en)
FR (1) FR2573427B1 (en)
GB (1) GB2167414B (en)
HU (1) HU195503B (en)
IE (1) IE58791B1 (en)
IT (1) IT1190426B (en)
LU (1) LU86163A1 (en)
MX (1) MX168415B (en)
NL (1) NL192387C (en)
NO (1) NO160205C (en)
PL (1) PL146890B1 (en)
PT (1) PT81532B (en)
SE (1) SE465676B (en)
SU (1) SU1436875A3 (en)
YU (1) YU43689B (en)
ZA (1) ZA858951B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
NZ560633A (en) * 2005-03-11 2011-08-26 Neuprotect Pty Ltd Flavonoid compounds and uses thereof
RU2482844C2 (en) * 2007-11-15 2013-05-27 Мадаус Гмбх Silibilin component for treating hepatitis
ES2374117T3 (en) 2007-11-15 2012-02-13 Madaus Gmbh SILIBININE COMPONENT FOR THE TREATMENT OF HEPATITIS.
CA2761656C (en) * 2009-05-14 2017-02-07 Lucio Claudio Rovati Amorphous silibinin for the treatment of viral hepatitis
WO2014008341A2 (en) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and magnesium
CN103172622B (en) * 2013-02-22 2015-11-04 西安安健药业有限公司 The active isomer of silybin bis-bias succinate
CN103113359B (en) * 2013-02-22 2016-01-06 西安安健药业有限公司 Silybin bis-bias succinate and pharmaceutical salts thereof
CN103193768B (en) * 2013-02-22 2016-03-30 西安安健药业有限公司 The silybin bis-bias succinate isomer for the treatment of hepatopathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (en) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybin esters with hepotoprotactant acti- - vity

Also Published As

Publication number Publication date
CS273610B2 (en) 1991-03-12
SE8505487L (en) 1986-05-23
YU178685A (en) 1988-02-29
SU1436875A3 (en) 1988-11-07
NO160205C (en) 1989-03-22
BE903693A (en) 1986-05-22
GB2167414A (en) 1986-05-29
FI84064B (en) 1991-06-28
CH659473A5 (en) 1987-01-30
NL192387C (en) 1997-07-04
SE8505487D0 (en) 1985-11-20
DD259191A1 (en) 1988-08-17
EG19424A (en) 1995-02-28
AT393268B (en) 1991-09-25
HUT40114A (en) 1986-11-28
LU86163A1 (en) 1986-03-24
PT81532B (en) 1987-11-11
AR240931A2 (en) 1991-03-27
CS837885A2 (en) 1990-08-14
NO160205B (en) 1988-12-12
PL146890B1 (en) 1989-03-31
SE465676B (en) 1991-10-14
IT8522932A0 (en) 1985-11-21
DE3442639A1 (en) 1986-05-22
DK164865C (en) 1993-01-18
GB8528226D0 (en) 1985-12-18
ES549116A0 (en) 1986-09-01
KR870001020B1 (en) 1987-05-23
ES8609311A1 (en) 1986-09-01
CA1337124C (en) 1995-09-26
DK537785D0 (en) 1985-11-21
KR860004056A (en) 1986-06-16
PT81532A (en) 1985-12-01
IE852808L (en) 1986-05-22
ATA337185A (en) 1991-02-15
IE58791B1 (en) 1993-11-17
AR240931A1 (en) 1991-03-27
FR2573427A1 (en) 1986-05-23
NL192387B (en) 1997-03-03
DE3442639C2 (en) 1989-08-10
JPH0432073B2 (en) 1992-05-28
FR2573427B1 (en) 1989-03-10
ZA858951B (en) 1986-08-27
PL256374A1 (en) 1986-12-02
YU43689B (en) 1989-10-31
HU195503B (en) 1988-05-30
JPS61143377A (en) 1986-07-01
NL8503171A (en) 1986-06-16
MX168415B (en) 1993-05-24
DK537785A (en) 1986-05-23
DK164865B (en) 1992-08-31
FI854535A0 (en) 1985-11-18
IT1190426B (en) 1988-02-16
NO854655L (en) 1986-05-23
FI854535A (en) 1986-05-23
FI84064C (en) 1991-10-10

Similar Documents

Publication Publication Date Title
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
IL72028A0 (en) Aminomethyl-oxooxazolidinylbenzene derivatives and pharmaceutical compositions containing them
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
IL75326A0 (en) Quinolone derivatives and pharmaceutical compositions containing them
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
IL76405A (en) 1,3-diacyl-2-oxindole derivatives and pharmaceutical compositions containing them
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
IL82205A (en) Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
NZ214175A (en) Cholecalciferol derivatives and pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
IL86711A0 (en) 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
IL75740A0 (en) Benzothiophene derivatives and pharmaceutical compositions containing them
NZ225466A (en) 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
DE3473444D1 (en) Acylindole derivatives and pharmaceutical compositions containing them
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
IL74071A0 (en) Dihydropyridine derivatives and pharmaceutical compositions containing them
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
IL73224A (en) 2-dioxacycloalkylthiopenem derivatives and pharmaceutical compositions containing them
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)